Description: Universal Ibogaine Inc. provides treatment for addiction patients in Canada. It provides ibogaine addiction treatment to patients suffering from opioid addiction; and operates clinics that offer non-medical detox, inpatient and outpatient treatment, and aftercare recovery programs, as well as addiction intervention services. The company was incorporated in 2018 and is based in Vancouver, Canada.
Home Page: universalibogaine.com
815 8th Avenue SW
Calgary,
AB
T2P 3P2
Canada
Phone:
855-426-4246
Officers
| Name | Title |
|---|---|
| Mr. Nicholas Peter Karos | CEO, Director of Capital Markets & Director |
| Mr. Greg J. Leavens C.A., CPA | CFO & Corporate Secretary |
| Mr. Shayne Nyquvest | Co-Founder |
| Mr. Dugan Selkirk | Manager Communications & Investor Relations |
| Cathy Fernandes | VP of Marketing & VP of Communications |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.8268 |
| Price-to-Sales TTM: | 1.8058 |
| IPO Date: | |
| Fiscal Year End: | July |
| Full Time Employees: | 0 |